SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing intense downward pressure driven by a combination of market-wide risk-off sentiment and concerns over recent legal losses regarding addictive platform design, triggering widespread retail debate on whether this is a buying opportunity or the start of a prolonged correction. Investors are closely monitoring massive AI-related capital expenditure and high-volume selling as the community debates the long-term impact of regulatory scrutiny versus the company's fundamental cash-generating strength.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is facing intense volatility as market participants react to escalating geopolitical tensions and erratic messaging surrounding potential military actions in the Middle East. The community is actively debating the stock's stability amidst heavy skepticism regarding official communications, with many users focusing on the broader impact of administration policies on both their portfolios and the global economy.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is trending due to significant volatility and ongoing debate regarding its future as an AI-integrated ecosystem, following reports of preliminary Q1 results that exceeded guidance and strategic moves to exit non-core ad businesses. While community sentiment is heavily polarized between investors identifying a potential short-squeeze opportunity and those concerned about long-term competition, many are focused on the upcoming GDC event as a pivotal catalyst for the stock's potential recovery.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is gaining traction as a community-driven brand, with holders actively promoting its ecosystem through IRL initiatives like custom merchandise, food products, and community events. Investors are showing high conviction in the project's long-term potential, frequently highlighting its persistent building efforts and worldwide brand-building strategy as key differentiators.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as shares surged following positive topline results from the Phase 3 GLOW2 study of Zenkuda for diabetic retinopathy, which met primary and secondary endpoints with high statistical significance. Community members are actively debating the potential for a short squeeze given high short interest, while some investors urge caution regarding future capital raises and long-term valuation.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently experiencing significant volatility as investors weigh the company's ambitious autonomous and robotics growth narrative against mounting regulatory scrutiny over its FSD technology and broader macroeconomic pressure from regional conflict. Market participants are actively debating the potential impact of a possible SpaceX IPO and the reliability of Tesla's future product promises, leading to intense speculation among both retail and institutional traders regarding the stock's near-term direction.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is experiencing significant downward pressure following its recent reverse stock split, as retail investors vent intense frustration over the lack of communication from management and the stock's persistent decline. The community is sharply divided, with some investors holding out for a potential short squeeze or buyout, while others are labeling the company a failing investment and bracing for further dilution.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending due to positive interim Phase 1 data for its obesity candidate WVE-007, which demonstrated promising visceral fat reduction and lean muscle preservation. The community is actively debating the trial's methodology regarding patient BMI while weighing the stock's significant volatility against a growing consensus of bullish analyst sentiment and potential long-term value in the obesity treatment space.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is seeing increased investor attention as the company enters a strategic ad partnership with Pacvue, aimed at expanding its enterprise-scale advertising capabilities. While the community remains divided over management's stock sales and the platform's long-term monetization potential, many traders are closely watching how the stock recovers from recent volatility.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is drawing significant investor interest following recent buyout speculation linking the company to potential acquirers like Eli Lilly, alongside positive momentum from institutional analysts raising price targets on the back of strong commercial performance. The community is actively debating the likelihood of a high-premium merger versus the potential for Madrigal to continue as a standalone leader in the MASH treatment space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Precision BioSciences (DTIL) Expected to Announce Earnings on Tuesday

Precision BioSciences (NASDAQ:DTIL) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 31. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-31-precision-biosciences-inc-stock...

Q1 EPS Estimate for Precision BioSciences Raised by Analyst

Precision BioSciences, Inc. (NASDAQ:DTIL - Free Report) - Stock analysts at HC Wainwright raised their Q1 2026 earnings per share (EPS) estimates for Precision BioSciences in a research note issued on Thursday, March 19th. HC Wainwright analyst P. Trucchio now anticipates that the company will earn...

Brokers Set Expectations for DTIL Q1 Earnings

Precision BioSciences, Inc. (NASDAQ:DTIL - Free Report) - Equities researchers at HC Wainwright issued their Q1 2027 earnings per share (EPS) estimates for Precision BioSciences in a research report issued on Thursday, March 19th. HC Wainwright analyst P. Trucchio anticipates that the company will p...

Precision BioSciences (NASDAQ:DTIL) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded Precision BioSciences from a "sell" rating to a "hold" rating in a report on Saturday...

Precision BioSciences (NASDAQ:DTIL) Trading Up 12.1% - Here's Why

Precision BioSciences (NASDAQ:DTIL) Stock Price Up 12.1% - What's Next...

Precision BioSciences (DTIL) Surpasses Q4 Earnings and Revenue Estimates

Precision BioSciences (DTIL) delivered earnings and revenue surprises of +271.43% and +178.08%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS platform to develop in vivo gene editing therapies for high unmet need...

Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program

Precision BioSciences Presents Preclinical PBGENE-DMD Data Highlighting Durable Dystrophin Expression and Functional Benefit at the Muscular Dystrophy Association Clinical & Scientific Conference 2026

Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates

Coherus Oncology (CHRS) delivered earnings and revenue surprises of -9.68% and -2.86%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC.

Precision Biosciences Inc

Alphabet $GOOGL

Robinhood $HOOD

Rocket Lab $RKLB

Sandisk $SNDK

The ticker that owned the conversation. This award honors the stock that defined the market narrative through engagement, price action, and cultural presence on the boards.

DTIL
Precision Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DTIL News

DTILPrecision Biosciences Inc